CAN-AM/LIFESCAN SETTLEMENT ALLOWS CONTINUED SALE OF GENERIC TEST STRIPS
This article was originally published in The Gray Sheet
Executive Summary
CAN-AM/LIFESCAN SETTLEMENT ALLOWS CONTINUED SALE OF GENERIC TEST STRIPS through a licensing arrangement. The deal is part of a Dec. 1 out-of-court settlement resolving patent litigation between Johnson & Johnson subsidiary LifeScan and the distributor, Can-Am Care, and manufacturer, Diagnostic Solutions, of Quick Check ONE blood glucose test strips. The Quick Check strips are marketed for use with LifeScan's One Touch blood glucose meters.